Interestingly, activation of at least some of the above signaling and transcriptional pathways has been shown to promote VDR, and RXRα expression, which may eventually represent a major cause for the sensitization of cancer cells to lower doses of 1,25D in the presence of phytochemicals or other enhancers of 1,25D action. The gene discussed is RXRA; the disease is cancer.